Bactericidal group IIA phospholipase A2 in serum of patients with bacterial infections

Journal of Infectious Diseases

Volumn 185, Issue 12, 2002, Pages 1767-1772

  Grönroos, Juha O ^a   Laine, Veli J O ^a   Nevalainen, Timo J ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; PHOSPHOLIPASE A2;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; CLINICAL ARTICLE; ESCHERICHIA COLI; FEMALE; HUMAN; IMMUNOADSORPTION; LISTERIA MONOCYTOGENES; MALE; PATHOGENESIS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANIMALS; BLOOD BACTERICIDAL ACTIVITY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; PHOSPHOLIPASES A; RABBITS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0037097770     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/340821     Document Type: Article

References (26)

1. Immunochemical detection of group I and group II phospholipases A2 in human serum
2. Serum phospholipase A2 in patients with multiple organ failure
3. Group II phospholipase A2 in sera of febrile patients with microbiologically or clinically documented infections
4. Would the real role(s) for secretory PLA2s please stand up
5. Origin of circulating group II phospholipase A2 in hepatocytes in a patient with epitheloid hemangioendothelioma of the liver
6. Expression of group II phospholipase A2 in the liver in acute pancreatitis
7. Human eosinophils express, relative to other circulating leukocytes, large amounts of secretory 14-kD phospholipase A2
8. The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2
9. Protection by group II phospholipase A2 against Staphylococcus aureus
10. Resistance of transgenic mice expressing human group II phospholipase A2 to Escherichia coli infection
11. Bactericidal properties of group IIA and group V phospholipases A2
12. Synovial type (group II) phospholipase A2 in cartilage
13. The expanding superfamily of phospholipase A2 enzymes: Classification and characterization
14. Increasing molecular diversity of secreted phospholipases A(2) and their receptors and binding proteins
15. Bactericidal properties of human and murine groups I, II, V, X, and XII secreted phospholipases A2
16. Protein volumes and hydration effects. The calculations of partial specific volumes, neutron scattering matchpoints and 280-nm absorption coefficients for proteins and glycoproteins from amino acid sequences
17. Structural determinants of the action against Escherichia coli of a human inflammatory fluid phospholipase A2 in concert with polymorphonuclear leukocytes
18. The antibacterial properties of secreted phospholipases A2: A major physiological role for the group IIA enzyme that depends on the very high pI of the enzyme to allow penetration of bacterial cell wall
19. Mobilization of potent plasma bactericidal activity during systemic bacterial challenge. Role of group IIA phospholipase A2
20. Secretory phospholipase A2 is the principal bactericide for staphylococci and other gram-positive bacteria in human tears
21. Determinants of activation by complement of group II phospholipase A2 acting against Escherichia coli
22. Groups IV, V, and X phospholipases A2s in human neutrophils. Role in eicosanoid production and gram negative bacterial phospholipid hydrolysis
23. Sera of patients suffering from inflammatory diseases contain group IIA but not group V phospholipase A2
24. Expression of human group II PLA2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate
25. Listeria pathogenesis and molecular virulence determinants
26. Listeria monocytogenes infects human endothelial cells by two distinct mechanisms